Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand signals. Read the full analysis here.

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

How exactly did basketball's greatest viral sensation end up spending the winter in Hoffman Estates? The answer isn't complicated. Guard Mac McClung, famous for winning three NBA dunk contests, had ...

Whether BCG strains other than BCG TICE are safe and effective for treating high-grade NMIBC warrants rigorous testing.

Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.

BASF SE’s BASFY Agricultural Solutions is strengthening its position as a global leader in canola advancement through a €17 million investment to expand and transform its Canola Breeding Centre of ...

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

After the Andover cold case ID, "we're going to continue solving cases and giving families answers," said the Texas DNA lab.

Manchester United's academy director explains how he plans to improve what has come before at a club "built on youth" ...

BID fed is the dose used in the ongoing Phase 3 ReDiscover-2 trial, which initiated mid-202511.1-month median PFS in heavily pre-treated ...